← FDA Drug Approvals (Drugs@FDA)
SITAGLIPTIN PHOSPHATE AND METFORMIN HYDROCHLORIDE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: PRINSTON PHARMACEUTICAL INC · Approved 2025-03-13
Drug application
- FDA Application #
ANDA216885- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- SITAGLIPTIN PHOSPHATE AND METFORMIN HYDROCHLORIDE
- Generic name
- Metformin Hydrochloride, Sitagliptin Phosphate
- Active ingredients
- METFORMIN HYDROCHLORIDE, SITAGLIPTIN PHOSPHATE
- Dosage form
- TABLET
- Route
- FILM COATED
- Marketing status
- None (Tentative Approval)
- Sponsor
- PRINSTON PHARMACEUTICAL INC
- First approval
- 2025-03-13
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown